Evaluation of the degree of tobacco addiction and the adequacy of orientation received by hospitalized smokers

Authors

DOI:

https://doi.org/10.11606/issn.1679-9836.v99i3p251-257

Keywords:

Tobacco use cessation, Hospitalization, Tobacco use disorder

Abstract

Introduction: Smoking is a chronic disease and a major risk factor for other diseases with high mortality. It’s physician’s duty to properly guide their patients to quit smoking. For that, the orientations must be scientifically based for effective management of the disease, with motivational interventions with or without pharmacotherapy. Objective: analyze the dependence degree of hospitalized smokers, using Fagerström test, comparing received orientations about quit smoking with pharmacological and non-pharmacological orientation present in literature. Methods: cross-sectional observational study with structured questionnaire applied to 60 smokers at the moment of hospital discharge from “Complexo Hospital de Clínicas da Universidade Federal do Paraná” (CHC/UFPR). Results: The patient sample was composed of 31 male patients and 29 female patients. 68.3% of the patients had more than 55 years. The median of the dependence degree was 5 (average degree). There was statistically significant difference between groups with present and absent orientation, regarding to the degree of motivation. 44.2% of the patients who had received orientation were in action phase, indicating that physicians guide more patients who already begun planning quit smoking. 35.3% of the patients with absent orientation were in pre-contemplation and 41.2% were in contemplation, suggesting that patients who don't have an insight to quit smoking are less oriented. Between correctly and incorrectly oriented groups, there was statistically significant difference in the type of hospital guidance. Among incorrectly oriented, 18 were oriented only motivationally, indicating an insufficient orientation trend. Conclusions: 51,2% of the orientations are performed incorrectly, expressing the need to re-evaluate the approach and treatment of smoking. There is the need of active search of smokers during the medical care and correct orientation for efficient treatment of the disease, addressing motivational side and pharmacotherapy.

Downloads

Download data is not yet available.

Author Biographies

  • Gabriel Bordignon, Universidade Federal do Paraná (UFPR)

    Trabalho realizado no Complexo Hospital de Clínicas da Universidade Federal do Paraná (CHC-UFPR).
    Acadêmico do curso de Medicina da Universidade Federal do Paraná, Curitiba-PR. 

  • Roddie Moraes Neto, Universidade Federal do Paraná (UFPR)

    Trabalho realizado no Complexo Hospital de Clínicas da Universidade Federal do Paraná (CHC-UFPR).
    Acadêmico do curso de Medicina da Universidade Federal do Paraná, Curitiba-PR. 

  • Gustavo Lenci Marques, Universidade Federal do Paraná (UFPR)

    Mestre em medicina interna. Professor adjunto do Departamento de Medicina Interna da Universidade Federal do Paraná, Curitiba, PR. 

References

Silva L, Araújo A, Queiroz A, Sales M, Sbpt M. Controle do tabagismo: desafios e conquistas. J Bras Pneumol. 2016;42(4):290-8. doi:10.1590/s1806-37562016000000145.

Pinto MT, Pichon-Riviere A, Bardach A. Estimativa da carga do tabagismo no Brasil: Mortalidade, morbidade e custos. Cad Saúde Pública. 2015;31(6):1283-97. doi:10.1590/0102-311X00192013.

Carter BD, Abnet CC, Feskanich D, et al. Smoking and mortality-beyond established causes. N Engl J Med. 2015;372(7):631-40. doi:10.1056/NEJMsa1407211.

Instituto Brasileiro de Geografia e Estatística (IBGE). Pesquisa Nacional de Saúde 2013. IBGE; 2014 [citado 20 ago. 2019]. Disponível em: http://biblioteca.ibge.gov.br/visualizacao/livros/liv91110.pdf. Published 2014.

Malta DC, Oliveira TP, Vieira ML, Almeida L, Szwarcwald CL. Uso e exposição à fumaça do tabaco no Brasil: resultados da Pesquisa Nacional de Saúde 2013. Epidemiol Serv Saúde. 2015;24(2):239-48. doi:10.5123/S1679-49742015000200006.

Brasil. Ministério da Saúde. Vigitel Brasil 2018: vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico. Brasília: Ministério da Saúde; 2019 [citado 15 ago. 2019]. Disponível em: https://portalarquivos2.saude.gov.br/images/pdf/2019/julho/25/vigitel-brasil-2018.pdf.

Pinto M, Bardach A, Palacios A, et al. Carga do tabagismo no Brasil e benefício potencial do aumento de impostos sobre os cigarros para a economia e para a redução de mortes e adoecimento. Cad Saúde Pública. 2019;35(8):e00129118. doi:10.1590/0102-311X00129118.

Instituto Nacional do Câncer. Protocolo Clínico e Diretrizes Terapêuticas - Dependência à Nicotina. Rio de Janeiro: INCA; 2014 [citado 20 ago. 2019]. Disponível em: http://www.saude.sp.gov.br/resources/cve-centro-de-vigilancia-epidemiologica/areas-de-vigilancia/doencas-cronicas-nao-transmissiveis/doc/dcnt/2014_diretrizes_inca_terapia_nicotina.pdf. Published 2014.

Reichert J, Araújo AJ de, Gonçalves CMC, et al. Diretrizes para cessação do tabagismo - 2008. J Bras Pneumol. 2008;34(10):845-80. doi:10.1590/S1806-37132008001000014.

European Network for Smoking and Tobacco Prevention aisbl (ENSP). Guidelines for treating tobacco dependence. Brussels: ENSP; 2018 [cited 2019 Aug 18]. Available from: http://elearning-ensp.eu/pluginfile.php/1052/mod_resource/content/2/guidelines_2018_english.pdf.

Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. Am J Respir Crit Care Med. 2017;195(5):557-82. doi:10.1164/rccm.201701-0218PP.

Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013;(5). doi:10.1002/14651858.CD009329.pub2.

Associação Médica Brasileira. Agência Nacional de Saúde Suplementar. Diretrizes Clínicas na Saúde Suplementar - Tabagismo. Brasília: AMB; 2011 [citado 19 ago. 2019].. Disponível em: https://diretrizes.amb.org.br/ans/tabagismo.pdf.

de Oliveira GMM, Mendes M, Dutra OP, et al. 2019: Recommendations for reducing tobacco consumption in Portuguese-speaking countries-positioning of the Federation of Portuguese Language Cardiology Societies. Arq Bras Cardiol. 2019;112(4):477-86. doi:10.5935/abc.20190071.

Liebmann EP, Scheuermann TS, Faseru B, Richter KP. Critical steps in the path to using cessation pharmacotherapy following hospital-initiated tobacco treatment. BMC Health Serv Res. 2019;19(1):246. doi:10.1186/s12913-019-4059-4.

Stefan MS, Pack Q, Shieh MS, et al. The association of nicotine replacement therapy with outcomes among smokers hospitalized for a major surgical procedure. Chest. 2020;157(5):1354-1361.doi:10.1016/j.chest.2019.10.054.

Rigotti NA, Clair C, Munafò MR, Stead LF. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev. 2012;(5). doi:10.1002/14651858.CD001837.pub3.

Lange P, Vestbo J. The Copenhagen City Heart Study Experience and its Key Contributions to Chronic Obstructive Pulmonary Disease. Barcelona Respir Netw. 2018;4(4). doi:10.23866/brnrev:2017-0022.

Siu AL. Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2015;163(8):622-34. doi:10.7326/M15-2023.

Cahill K, Lancaster T, Green N. Stage-based interventions for smoking cessation. Cochrane Database Syst Rev. 2010;(11). doi:10.1002/14651858.CD004492.pub4.

Published

2020-06-12

Issue

Section

Artigos/Articles

How to Cite

Bordignon, G., Moraes Neto, R., & Marques, G. L. (2020). Evaluation of the degree of tobacco addiction and the adequacy of orientation received by hospitalized smokers. Revista De Medicina, 99(3), 251-257. https://doi.org/10.11606/issn.1679-9836.v99i3p251-257